Zydus Healthcare Limited
Phone 022-62721700
AddressZydus Healthcare Limited,
Zydus Tower, CTS No. 460/6,
Village Pahadi. Off I.B. Patel Road,
Goregaon East, Mumbai - 400063
BEMDAC is a novel drug exhibiting unique mechanism of action, via inhibition of ATP Citrate Lyase (ACL), an enzyme upstream to HMG CoA reductase in the cholesterol synthesis pathway. This helps bridging an unmet need in the management of patients who are on maximally tolerated statin therapy, yet require additional lowering of LDL-c.
BEMDAC is a prescription product, please consult your physician for more details.
Bemdac is indicated as an adjunct to diet and maximally tolerated statins therapy for the treatment of adults with Heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDLc.